Abstract: This disclosure describes a new antibacterial agent designated LL-C23201.delta., produced in a microbiological fermentation under controlled conditions using a new strain of Streptomyces olivaceo-griseus, sp. nov. and mutants thereof. This new antibacterial agent is active against a variety of microorganisms and thus is useful in inhibiting the growth of such bacteria wherever they may be found.
Type:
Grant
Filed:
June 20, 1983
Date of Patent:
December 9, 1986
Assignee:
American Cyanamid Company
Inventors:
David P. Labeda, Joseph J. Goodman, John H. E. J. Martin, deceased
Abstract: This invention concerns 1-aryl-3-azabicyclo[3.2.0]heptanes and their acid-addition salts. More particularly, this invention pertains to compositions useful for treatment of depression in warm-blooded animals.
Type:
Grant
Filed:
November 21, 1983
Date of Patent:
October 1, 1985
Assignee:
American Cyanamid Company
Inventors:
Joseph W. Epstein, Thomas C. McKenzie, William J. Fanshawe
Abstract: This invention relates to a novel method for the treatment of malarial infections in warm-blooded animals using the antibiotics X-14868A, LL-C23024 beta, LL-C23024 iota, and combinations theory and to compositions containing these antibiotics.